TipRanks
Altimmune Inc (ALT)
NASDAQ:ALT
US Market
ALT
Altimmune
RESEARCH TOOLSreports
Want to see ALT full AI Analyst Report?

Altimmune (ALT) Drug Pipeline

3,797 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Pemvidutide
Metabolic Dysfunction-Associated Steatohepatitis (Mash)
Phase III
Recruiting
Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH
Aug 14, 2026
―
Pemvidutide
Alcohol Liver Disease
Phase II
Active Not Recruiting
RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Jun 05, 2025
Pemvidutide
Alcohol Use Disorder (Aud)
Phase II
Completed
RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
May 16, 2025
Pemvidutide
Non-Alcoholic Steatohepatitis (Nash)
Phase II
Completed
IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
Jul 24, 2023
Alt-801
Type 2 Diabetes
Phase I
Completed
ALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)
Nov 15, 2021
―
Metformin, Digoxin, Warfarin, Atorvastatin, Pemvidutide, Ethinylestradiol And Levonorgestrel
Nash - Nonalcoholic Steatohepatitis
Phase I
Completed
Pemvidutide (ALT-801) DDI Study in Healthy Volunteers
Jul 14, 2021
―
Alt-801
Obesity, Nonalcoholic Steatohepatitis
Phase I
Completed
ALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability
Sep 16, 2020
―
Nasoshield
Healthy Volunteers
Phase I
Completed
NasoShield in Healthy Adults to Study Safety and Immunogenicity
Jun 01, 2020
―
Biothrax, Nasoshield
Healthy Volunteers
Phase I
Completed
NasoShield Study of Safety and Immunogenicity
Nov 21, 2017
―
Fp-02.2 Vaccine, Ic31 Adjuvant
Hepatitis B
Phase I
Completed
Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
Jul 06, 2015
―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Altimmune Inc (ALT) have in its pipeline
      ALT is currently developing the following drugs: Pemvidutide, Pemvidutide, Pemvidutide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.